Paper11040176
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
Markowitz J and 4 others. Gastroenterology, 2000. Cited by 562 papers, by iCite.
Cite this record
ConductScience Library. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Papers, record 11040176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11040176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Crohn Disease | Major topic |
| Immunosuppressive Agents | Major topic |
| Mercaptopurine | Major topic |
| Prednisone | Major topic |
| Adolescent | |
| Child | |
| Disease-Free Survival | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| Glucocorticoids | |
| Growth | |
| Humans | |
| Male | |
| Prospective Studies |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02852694 | Reduce Risk for Crohn's Disease Patients | Background |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 11040202 | 6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero. | https://conductscience.org/library/papers/11040202 | PubMed |
| Comment in | 11353560 | 6-Mercaptopurine for children newly diagnosed with Crohn's disease. | https://conductscience.org/library/papers/11353560 | PubMed |
Cited by159
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 562 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42099516 | Enteral nutrition versus immunomodulators for induction and maintenance of remission in pediatric Crohn's disease: a systematic review and network meta-analysis. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42099516 | PubMed |
| 41532979 | Combining thiopurine with partial enteral nutrition promotes complete mucosal healing in pediatric Crohn's disease. | Pediatr Int | 2026 | https://conductscience.org/library/papers/41532979 | PubMed |
| 41323518 | Evolution of Growth following Anti-Tumor Necrosis Factor-α Therapy in Paediatric Crohn's Disease: Data from the Swiss IBD Cohort Study. | Inflamm Intest Dis | 2025 | https://conductscience.org/library/papers/41323518 | PubMed |
| 41300822 | Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41300822 | PubMed |
| 41274746 | AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease. | Gastroenterology | 2025 | https://conductscience.org/library/papers/41274746 | PubMed |
| 39200937 | Common Mistakes in Managing Patients with Inflammatory Bowel Disease. | J Clin Med | 2024 | https://conductscience.org/library/papers/39200937 | PubMed |
| 38788739 | Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients. | Inflamm Bowel Dis | 2024 | https://conductscience.org/library/papers/38788739 | PubMed |
| 37967391 | Diagnostic Considerations in Pediatric Inflammatory Bowel Disease Management. | Gastroenterol Hepatol (N Y) | 2009 | https://conductscience.org/library/papers/37967391 | PubMed |
| 37787346 | Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn's disease: A systematic review and meta-analysis. | Saudi J Gastroenterol | 2023 | https://conductscience.org/library/papers/37787346 | PubMed |
| 37695555 | Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease. | Curr Gastroenterol Rep | 2023 | https://conductscience.org/library/papers/37695555 | PubMed |
| 37338669 | Inflammatory Bowel Disease in Children. | Indian J Pediatr | 2024 | https://conductscience.org/library/papers/37338669 | PubMed |
| 37240524 | Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease. | J Clin Med | 2023 | https://conductscience.org/library/papers/37240524 | PubMed |
| 37215203 | Efficacy of short-chain polypeptide-based EEN formulas in alleviating intestinal injury in children with Crohn's disease: a single-center study in China. | Front Nutr | 2023 | https://conductscience.org/library/papers/37215203 | PubMed |
| 36798512 | Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease. | Crohns Colitis 360 | 2020 | https://conductscience.org/library/papers/36798512 | PubMed |
| 36123761 | Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. | J Pediatr Gastroenterol Nutr | 2023 | https://conductscience.org/library/papers/36123761 | PubMed |
| 36008595 | Prediction of thiopurine failure in pediatric Crohn's disease: pediatric IBD Porto group of ESPGHAN. | Pediatr Res | 2023 | https://conductscience.org/library/papers/36008595 | PubMed |
| 35687221 | Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/35687221 | PubMed |
| 35401955 | Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review. | Frontline Gastroenterol | 2021 | https://conductscience.org/library/papers/35401955 | PubMed |
| 35368318 | Recommendation Reversals in Gastroenterology Clinical Practice Guidelines. | J Can Assoc Gastroenterol | 2022 | https://conductscience.org/library/papers/35368318 | PubMed |
| 33532972 | Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study. | Dig Dis Sci | 2022 | https://conductscience.org/library/papers/33532972 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11040176
GET https://conductscience.org/api/papers/v1/11040176/cited_by?page=2